Moderna said the pivotal last-stage study of its experimental coronavirus vaccine began Monday, with the first subjects receiving doses
Two of the most advanced experimental coronavirus vaccines entered the pivotal phase of their studies on Monday, with the first subjects receiving doses of Moderna Inc.’s vaccine and Pfizer Inc. readying to inject participants in its trial.
Researchers evaluating the vaccines plan to enroll 30,000 people in separate last-stage, or phase 3 trials, results of which will determine whether the vaccines protect against symptomatic Covid-19, and whether they should be cleared for widespread use.
Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
Pfizer and BioNTech began late-stage human trial for coronavirus vaccine Monday
Weiterlesen »
Stocks making the biggest moves after hours: Pfizer, F5 Networks, Virgin Galactic and moreSee which stocks are posting big moves after the bell.
Weiterlesen »
Moderna’s Coronavirus Vaccine Begins Final-Stage TestingModerna’s pivotal vaccine trial will evaluate, in 30,000 subjects across the U.S., whether two doses protects against symptomatic Covid-19
Weiterlesen »
Pfizer and BioNTech began late-stage human trial for coronavirus vaccine Monday
Weiterlesen »
Final test of Moderna's coronavirus vaccine — in 30,000 volunteers — gets underwayThe world's biggest COVID-19 vaccine test got underway Monday with the first of 30,000 planned volunteers.
Weiterlesen »
COVID Vaccine Candidate Now in Final Phase TestingThis is only one of the many vaccines under development worldwide. Other trials are underway in China and Britain, and final tests have started in Brazil and other countries.
Weiterlesen »